SCHEMBL1879713

SCHEMBL1879713

O=c1ccsn1Cc1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 1.00
G6PD P11413 2/20 1.00
HPGD P15428 2/20 1.00
ALOX15 P16050 2/20 1.00
HSD17B10 Q99714 2/20 1.00
MAPT P10636 2/20 1.00
PKM P14618 1/20 1.00
HTT P42858 1/20 1.00
TDP1 Q9NUW8 1/20 1.00
GSK3B P49841 6/20 0.49
GSK3A P49840 5/20 0.49
TP53 P04637 1/20 0.49
HSP90AA1 P07900 1/20 0.49
CYP3A4 P08684 1/20 0.49
TSHR P16473 1/20 0.49
HIF1A Q16665 1/20 0.49
CASP3 P42574 1/20 0.47
KAT2B Q92831 2/20 0.47
EP300 Q09472 1/20 0.47
F2 P00734 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9320078 0.98 ALDH1A1 (0.96) ALDH1A1G6PDHPGDALOX15HSD17B10
Hydrochloric Acid SCHEMBL11708755 0.96 ALDH1A1 (0.93) ALDH1A1G6PDHPGDALOX15HSD17B10
Hydrochloric Acid SCHEMBL11708748 0.96 ALDH1A1 (0.93) ALDH1A1G6PDHPGDALOX15HSD17B10
Chloroacetic Acid SCHEMBL9321136 0.90 ALDH1A1 (0.81) ALDH1A1G6PDHPGDALOX15HSD17B10
SCHEMBL7695911 0.88 ALDH1A1 (0.78) ALDH1A1G6PDHPGDALOX15HSD17B10
SCHEMBL5593792 0.84 ALDH1A1 (0.71) ALDH1A1G6PDHPGDALOX15HSD17B10
SCHEMBL7307539 0.83 MAPT (0.70) ALDH1A1G6PDHPGDALOX15HSD17B10
SCHEMBL9319689 0.82 ALDH1A1 (0.70) ALDH1A1G6PDHPGDALOX15HSD17B10
SCHEMBL2808252 0.82 ALDH1A1 (0.70) ALDH1A1G6PDHPGDALOX15HSD17B10
SCHEMBL5593583 0.81 ALDH1A1 (0.68) ALDH1A1G6PDHPGDALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 266 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3877349-A1 COMPOSITION FOR A VERY DURABLE PASTY FILL AND FINISHING MATERIAL, PASTY FILL AND FINISHING MATERIAL, AND METHOD FOR PRODUCING IT Knauf Gips KG (DE) 2021-09-15 EP claimed
US-7934888-B2 Marine anti-foulant system and methods for using same VIV SUPPRESSION, INC. (US) 2011-05-03 US claimed
US-20090185867-A1 MARINE ANTI-FOULANT SYSTEM AND METHODS FOR USING SAME ASSET INTEGRITY MANAGEMENT SOLUTIONS, L.L.C., D/B/A AIMS INTERNATIONAL 2009-07-23 US claimed
EP-0774978-B1 METHOD OF TREATING INANIMATE SURFACES WITH UNCOMPLEXED CYCLODEXTRIN SOLUTIONS FOR ODOR CONTROL PROCTER & GAMBLE (US) 2006-11-15 EP claimed
CN-1229022-C Control release composition ROHM & HAAS (US) 2005-11-30 CN claimed
EP-1142477-B1 Controlled release compositions ROHM & HAAS (US) 2004-06-02 EP claimed
EP-0776220-B1 FABRIC TREATING COMPOSITION CONTAINING BETA-CYCLODEXTRIN PROCTER & GAMBLE (US) 2004-04-21 EP claimed
US-6682694-B2 REMOVING MALODORS BY PROVIDING UNCOMPLEXED CYCLODEXTRIN SOLUTION CONTAINING WATER-SOLUBLE ANTIMICROBIAL PRESERVATIVE; STORAGE STABILITY THE PROCTER & GAMBLE COMPANY 2004-01-27 US claimed
US-6676954-B2 COMPRISING A 3-ISOTHIAZOLONE COMPOUND HAVING LOW WATER SOLUBILITY AND A CARBON-BASED ADSORBENT IN SOLID FORM; USE SUCH AS TO INHIBIT THE GROWTH OF MARINE ORGANISMS IN PAINTS AND COATINGS ROHM AND HAAS COMPANY 2004-01-13 US claimed
US-20020128311-A1 Halocyanoacetamide antimicrobial compositions GIRONDA KEVIN F (US) 2002-09-12 US claimed
EP-0776220-A1 FABRIC TREATING COMPOSITION CONTAINING BETA-CYCLODEXTRIN THE PROCTER & GAMBLE COMPANY (US) 1997-06-04 EP claimed
EP-0774978-A1 UNCOMPLEXED CYCLODEXTRIN SOLUTIONS FOR ODOR CONTROL OR INANIMATE SURFACES THE PROCTER & GAMBLE COMPANY (US) 1997-05-28 EP claimed
EP-0775229-A1 UNCOMPLEXED CYCLODEXTRIN SOLUTIONS FOR ODOR CONTROL ON INANIMATE SURFACES THE PROCTER & GAMBLE COMPANY (US) 1997-05-28 EP claimed
US-5593670-A ODOR ABSORBER FOR FABRICS THE PROCTOR & GAMBLE COMPANY (US) 1997-01-14 US claimed
US-5534165-A Fabric treating composition containing beta-cyclodextrin and essentially free of perfume THE PROCTER & GAMBLE COMPANY (US) 1996-07-09 US claimed
WO-1996004939-A1 FABRIC TREATING COMPOSITION CONTAINING BETA-CYCLODEXTRIN THE PROCTER & GAMBLE COMPANY (US) 1996-02-22 WO claimed
WO-1996004937-A1 UNCOMPLEXED CYCLODEXTRIN SOLUTIONS FOR ODOR CONTROL ON INANIMATE SURFACES THE PROCTER & GAMBLE COMPANY (US) 1996-02-22 WO claimed
WO-1996005358-A1 UNCOMPLEXED CYCLODEXTRIN SOLUTIONS FOR ODOR CONTROL ON INANIMATE SURFACES THE PROCTER & GAMBLE COMPANY (US) 1996-02-22 WO claimed
US-5465527-A Landscaping border ABLE CORPORATION (US) 1995-11-14 US claimed
US-4900736-A Salts of alkyl-2-benzimidazole-carbamate and fungicidal compositions thereof suitable for paints and plaster SCHULKE MAYR, GMBH (DE) 1990-02-13 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128311-A1 Halocyanoacetamide antimicrobial compositions HDHD5, DGKI, DAGLA ALDH1A1 2941/4885G6PD 3211/4885HPGD 476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.